Holen Sie sich die Stockscreener-App
7.08
1.94%
-0.14
Schlusskurs vom Vortag:
$7.22
Offen:
$7.03
24-Stunden-Volumen:
1.45M
Relative Volume:
0.98
Marktkapitalisierung:
$774.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-242.30M
KGV:
-2.8548
EPS:
-2.48
Netto-Cashflow:
$-192.10M
1W Leistung:
+4.12%
1M Leistung:
+41.88%
6M Leistung:
-13.13%
1J Leistung:
-21.16%
1-Tages-Spanne:
$6.8834
$7.285
1-Wochen-Bereich:
$6.59
$7.64
52-Wochen-Spanne:
$3.72
$12.61
Cogent Biosciences Inc Stock (COGT) Company Profile
Firmenname
Cogent Biosciences Inc
Sektor
Branche
Telefon
617-945-5576
Adresse
275 WYMAN STREET, WALTHAM
Vergleichen Sie COGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
7.08 | 774.22M | 0 | -242.30M | -192.10M | -2.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-11 | Herabstufung | Needham | Buy → Hold |
| 2024-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | Eingeleitet | Citigroup | Buy |
| 2023-12-11 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-12-08 | Eingeleitet | JP Morgan | Overweight |
| 2023-04-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-03-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-06-28 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-06-09 | Fortgesetzt | Jefferies | Buy |
| 2020-12-23 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Cogent Biosciences Inc Aktie (COGT) Neueste Nachrichten
Bank of America Corp DE Reduces Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Term Loan Facility - Leerink Partners
Cogent Biosciences, Inc. (NASDAQ:COGT) Stock Position Lowered by California State Teachers Retirement System - Defense World
Cogent Biosciences Secures $400 Million in Financing - citybiz
Cogent Biosciences, Inc. announced that it expects to receive $400 million in funding - marketscreener.com
Cogent Biosciences Gets $400 Million Debt Financing - marketscreener.com
Cogent Biosciences (COGT) Secures $400M Financing for Growth Ini - GuruFocus
Cogent Secures Up To $400 Mln Debt Facility From SLR Capital For Growth Strategy - Nasdaq
Cogent Biosciences Secures $400 Million Debt Financing Facility to Support Growth and Upcoming Bezuclastinib Launch - Nasdaq
Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing - GlobeNewswire
Cogent Biosciences Lands Massive $400M Financing Deal as 3 Pivotal Trial Results Loom in 2025 - Stock Titan
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 17,741 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Two Sigma Investments LP Sells 4,633 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Two Sigma Advisers LP Has $148,000 Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Ameriprise Financial Inc. Acquires 9,459 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
(COGT) On The My Stocks Page - news.stocktradersdaily.com
Nuveen Asset Management LLC Has $2.44 Million Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
ProShare Advisors LLC Increases Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences (NASDAQ:COGT) Trading Down 5.7% – Time to Sell? - Defense World
Cogent Biosciences (NASDAQ:COGT) Price Target Raised to $25.00 at JPMorgan Chase & Co. - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences (NASDAQ:COGT) Shares Up 11.6% Following Analyst Upgrade - Defense World
COGT: JP Morgan Raises Price Target for Cogent Biosciences | COG - GuruFocus
Cogent Biosciences Announces Participation in the Jefferies Glob - GuruFocus
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference - GlobeNewswire
Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference | COGT Stock News - GuruFocus
JPMorgan Ups Price Target for Cogent Biosciences (COGT) to $25 | - GuruFocus
Cogent Biosciences Reveals Latest Precision Therapy Progress Plus New Employee Stock Options - Stock Titan
Deutsche Bank AG Reduces Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Jane Street Group LLC Decreases Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
This Cogent Biosciences Insider Increased Their Holding By 2,085% Last Year - simplywall.st
When (COGT) Moves Investors should Listen - news.stocktradersdaily.com
BNP Paribas Financial Markets Buys Shares of 66,784 Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Janus Henderson Group PLC Has $227,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Q2 EPS Estimate for Cogent Biosciences Raised by Analyst - Defense World
HC Wainwright Has Lowered Expectations for Cogent Biosciences (NASDAQ:COGT) Stock Price - Defense World
Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) PT at $14.29 - Defense World
Cogent Biosciences (COGT) Maintains 'Buy' Rating with Adjusted P - GuruFocus
Cogent Biosciences (COGT) Maintains 'Buy' Rating with Adjusted Price Target | COGT Stock News - GuruFocus
Cogent Biosciences (COGT) Price Target Reduced by H.C. Wainwrigh - GuruFocus
Northern Trust Corp Grows Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Where are the Opportunities in (COGT) - news.stocktradersdaily.com
Price T Rowe Associates Inc. MD Has $388,000 Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Wall Street Analysts Believe Cogent Biosciences (COGT) Could Rally 224.37%: Here's is How to Trade - MSN
Voya Investment Management LLC Sells 2,333 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Why Cogent Biosciences (COGT) Is One of the Best Low Priced Biotech Stocks to Buy Now - MSN
Hsbc Holdings PLC Purchases Shares of 10,674 Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey
Q2 EPS Estimate for Cogent Biosciences Lifted by Analyst - Defense World
Dimensional Fund Advisors LP Lowers Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):